✦ LIBER ✦

Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B Patients With High Viral Load and/or High Fibrosis Scores at Week 48 of Therapy

✍ Scribed by Kurdas Ovunc, Ayse O. ;Guzelbulut, Fatih ;Senates, Ebubekir ;Gökden, Yasemin ;Degirmenci Salturk, Ayca G. ;Akkan Çetinkaya, Züleyha ;Sezikli, Mesut ;Ozkara, Selvinaz ;Çetinkaya, Fuat

Book ID: 122293384
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 588 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63860-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of tenofovir disoproxil fumarat

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

✍ Gordon, Stuart C.; Krastev, Zahary; Horban, Andrzej; Petersen, Jörg; Sperl, Jan; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

22 A COMPARISON OF 24 WEEKS AND 48 WEEKS

22 A COMPARISON OF 24 WEEKS AND 48 WEEKS TREATMENT EFFICACY BETWEEN CLEVUDINE AND ENTECAVIR THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B

✍ S.R. Shin; D.H. Lee; S.M. Song; M.S. Choi; J.H. Lee; K.C. Koh; S.W. Paik; B.C. Y 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A comparison of 48-week treatment effica

A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B

✍ Su Rin Shin; Byung Chul Yoo; Moon Seok Choi; Dong Ho Lee; Soon Mi Song; Joon Hyo 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 243 KB

636 High Rate of Complete Viral Suppress

636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure

✍ Wong, Carrie R.; Trinh, Huy N.; Garcia, Ruel T.; Nguyen, Huy A.; Nguyen, Khanh K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Sustained viral load and ALT reduction f

Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in HBEAG-negative and -positive patients with chronic hepatitis B who have failed prior lamivudine therapy

✍ R. Gish; T.T. Chang; S. Hadziyannis; J. Cianciara; M. Rizzetto; E. Schiff; G. Pa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Efficacy of reduction therapy of natural

Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral load

✍ Yasuji Arase; Yusuke Kawamura; Yoshiyuki Suzuki; Fumitaka Suzuki; Norio Akuta; N 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB